Department of Trauma-, Hand- and Reconstructive Surgery, University Hospital Frankfurt, Goethe-University, Frankfurt, Germany.
Front Immunol. 2023 Mar 9;14:1107150. doi: 10.3389/fimmu.2023.1107150. eCollection 2023.
Trauma is still a leading cause of morbidity and mortality, especially in the younger population. Trauma patients need a precise, early diagnostic to avoid complications like multiorgan failure and sepsis. Exosomes were described as markers and mediators in trauma. The aim of the present study was to analyze, whether the surface epitopes of plasma-exosomes can reflect the injury pattern in polytrauma.
Polytraumatized patients (Injury Severity Score = ISS ≥16, n = 38) were subdivided according to the predominant injury in either abdominal trauma, chest trauma or traumatic brain injury (TBI). Plasma exosomes were isolated via size exclusion chromatography. The concentration and size distribution of the plasma exosomes from emergency room samples were measured by nanoparticle tracking analysis. The exosomal surface antigens were investigated by bead-based multiplex flow cytometry and compared with healthy controls (n=10).
In contrast to other studies, we did not observe an increase in the total amount of plasma exosomes in polytrauma patients (1,15x109 vs. 1,13x109 particles/ml), but found changes in the exosomal surface epitopes. We found a significant reduction of CD42a+ (platelet-derived) exosomes in polytrauma patients, CD209+ (dendritic cell-derived) exosomes in the patients with predominant abdominal trauma, and CD11+ (monocyte-derived) exosomes in the patients with chest trauma. The group of patients with TBI was characterized in contrast by an increase of CD62p+ (endothelial/platelet-derived) exosomes (*p<0.05).
Our data showed that the polytrauma injury pattern might be reflected by the cellular origin/surface epitopes of plasma-released exosomes immediately after trauma. The observed reduction of CD42+ exosomes in polytrauma patients was not associated with a reduction of total platelets in polytrauma patients.
创伤仍然是发病率和死亡率的主要原因,尤其是在年轻人群中。创伤患者需要精确、早期的诊断,以避免多器官衰竭和败血症等并发症。外泌体被描述为创伤中的标志物和介质。本研究旨在分析血浆外泌体的表面表位是否能反映多发伤中的损伤模式。
将多发伤患者(损伤严重度评分=ISS≥16,n=38)根据主要损伤分为腹部创伤、胸部创伤或创伤性脑损伤(TBI)。通过尺寸排阻色谱法分离血浆外泌体。通过纳米颗粒跟踪分析测量急诊样本中外泌体的浓度和大小分布。通过基于珠的多重流式细胞术研究外泌体表面抗原,并与健康对照者(n=10)进行比较。
与其他研究不同,我们没有观察到多发伤患者血浆外泌体总量增加(1.15×109vs.1.13×109个/毫升),但发现外泌体表面表位发生了变化。我们发现多发伤患者的 CD42a+(血小板衍生)外泌体显著减少,主要为腹部创伤的患者的 CD209+(树突状细胞衍生)外泌体减少,而胸部创伤的患者的 CD11+(单核细胞衍生)外泌体减少。相反,TBI 组的特征是 CD62p+(内皮/血小板衍生)外泌体增加(*p<0.05)。
我们的数据表明,多发伤损伤模式可能反映在创伤后立即释放的血浆外泌体的细胞起源/表面表位上。多发伤患者中 CD42+外泌体的减少与多发伤患者总血小板减少无关。